Quest Diagnostics (DGX) Invested Capital (2009 - 2026)

Quest Diagnostics has disclosed Invested Capital across 18 years of filings, most recently posting $8.2 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $8.2 billion, up 13.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.2 billion (up 13.82% YoY), and the FY2025 annual result was $12.8 billion, down 1.45% from the prior year.
• Invested Capital came in at $8.2 billion for Q1 2026 at Quest Diagnostics, down from $12.8 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.1 billion in Q3 2024 to a low of $6.1 billion in Q1 2023.
• The 5-year median for Invested Capital is $7.4 billion (2024), against an average of $8.5 billion.
• Across the five-year window, Invested Capital soared 93.47% in 2024 and sank 40.71% in 2025, its largest moves.
• Quest Diagnostics' Invested Capital stood at $9.9 billion in 2022, then grew by 11.55% to $11.1 billion in 2023, then advanced by 17.87% to $13.0 billion in 2024, then dropped by 1.45% to $12.8 billion in 2025, then slumped by 36.38% to $8.2 billion in 2026.
• The last three Invested Capital figures came in at $8.2 billion (Q1 2026), $12.8 billion (Q4 2025), and $7.8 billion (Q3 2025), per Business Quant data.